Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 28 patents granted in the last 365 days
Top Glory Trading Group Inc. has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. All 3 of these actions are located within 1 distinct art unit, which suggests that the company's patent applications are technically similar. However, the prosecution is split among 3 distinct examiners, so each pending action is being reviewed by a different person.
KATHARINE GRACZ KANE is the busiest examiner for the company, currently managing 1 pending office action. This accounts for a portion of the total 3 pending actions in the portfolio. While the 1 distinct art unit provides a consistent procedural framework, the involvement of 3 distinct examiners means the company must address three different individual perspectives to resolve the 3 pending office actions.
The concentration of 3 pending office actions in 1 art unit within the Medical Devices & Mechanical Engineering field allows for a focused prosecution strategy. Even with 3 distinct examiners, the shared art unit environment may lead to similar examination patterns. Practitioners should look for consistency in how the 1 art unit handles these mechanical claims within the Medical Devices & Mechanical Engineering technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KANE, KATHARINE GRACZ | 1 | 47.7% | +45.7% |
| REDHEAD, AKWOKWO OLABISI | 1 | 41.2% | +35.5% |
| PIERORAZIO, JILLIAN KUTCH | 1 | 59.0% | +32.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19289442 | SOLE AND FOOTWEAR HAVING THE SOLE | KANE, KATHARINE GRACZ | 16d overdue |
| 19019902 | HEEL CUP AND SHOE | PIERORAZIO, JILLIAN KUTCH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19289442 | SOLE AND FOOTWEAR HAVING THE SOLE | KANE, KATHARINE GRACZ | 16d overdue |
| 19289456 | SOLE AND FOOTWEAR HAVING THE SOLE | REDHEAD, AKWOKWO OLABISI | — |
| 19019902 | HEEL CUP AND SHOE | PIERORAZIO, JILLIAN KUTCH | — |
| Art Unit | Apps |
|---|---|
| 3732 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19289442 | SOLE AND FOOTWEAR HAVING THE SOLE | KANE, KATHARINE GRACZ | 3732 | §103§112 | Final Rejection | 16d overdue | Pending | Aug 04, 2025 |
| 19289456 | SOLE AND FOOTWEAR HAVING THE SOLE | REDHEAD, AKWOKWO OLABISI | 3732 | §103 | Final Rejection | — | Pending | Aug 04, 2025 |
| 19019902 | HEEL CUP AND SHOE | PIERORAZIO, JILLIAN KUTCH | 3732 | §102§103§112 | Non-Final OA | — | Pending | Jan 14, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial